Aurisco(SH:605116) Xin Lang Cai Jing·2026-01-16 03:09Group 1 - The core point of the news is that Aorite's stock has seen a significant increase, rising 5.02% to 34.10 CNY per share, with a total market capitalization of 13.851 billion CNY and a cumulative increase of 26.74% over the past seven days [1] - Aorite Pharmaceutical Co., Ltd. is located in Tiantai County, Zhejiang Province, and was established on March 5, 1998. It was listed on September 21, 2020, focusing on the research, production, and sales of specialty APIs and pharmaceutical intermediates [1] - The company's main business revenue composition includes 85.12% from API and intermediate sales, 11.64% from finished drug sales, 2.74% from import and export trade, and 0.50% from other sources [1] Group 2 - From the perspective of major fund holdings, the Guoshou Anbao Fund has a significant position in Aorite, with its Guoshou Anbao Health Science Mixed A Fund holding 210,000 shares, representing 9.07% of the fund's net value [2] - The fund has generated a floating profit of approximately 342,300 CNY today and a total of 1,438,500 CNY during the seven-day increase [2] - The Guoshou Anbao Health Science Mixed A Fund was established on November 1, 2017, with a latest scale of 5.3363 million CNY and has achieved a year-to-date return of 6.63% [2]